• Home

  • Documents

  • PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth....
16

PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 2: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 3: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 4: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 5: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 6: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 7: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 8: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 9: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 10: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 11: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 12: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 13: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 14: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 15: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg
Page 16: PowerPoint Presentation...Week 28 Week 52 19.1 Week 104 11.9 Week 156 Week . 270-201 : I Isth. Disccway Durable FVIII Activity Expression with Plateau Forming in Years 2-3 6*1013 vg/kg

Supplementary Information - Dendritics · Protein/factor VIII replacement therapy. A combination therapy of Flt3L/rapamycin/0.3 IU FVIII (B domain-deleted recombinant human FVIII,

Supplementary Information - Dendritics · Protein/factor VIII replacement therapy. A combination therapy of Flt3L/rapamycin/0.3 IU FVIII (B domain-deleted recombinant human FVIII,

Documents
ISTH International Society on Thrombosis and Haemostasis

ISTH International Society on Thrombosis and Haemostasis

Documents
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von

Documents
POST-ISTH: NOVITÀ DAL MEETING DI TORONTO … · POST-ISTH: NOVITÀ DAL MEETING DI TORONTO 2015 Piastrinopenie e piastrinopatie Patrizia NORIS Fondazione IRCCS Policlinico San Matteo

POST-ISTH: NOVITÀ DAL MEETING DI TORONTO … · POST-ISTH: NOVITÀ DAL MEETING DI TORONTO 2015 Piastrinopenie e piastrinopatie Patrizia NORIS Fondazione IRCCS Policlinico San Matteo

Documents
and the ISTH SSC guideline time for an update?

and the ISTH SSC guideline time for an update?

Documents
Learn about managing hemophilia A with KOĀTE, a plasma ......hemophilia A with KOĀTE, a plasma-derived FVIII/VWF* complex. *FVIII: factor VIII; VWF: von Willebrand factor. APPROVED

Learn about managing hemophilia A with KOĀTE, a plasma ......hemophilia A with KOĀTE, a plasma-derived FVIII/VWF* complex. *FVIII: factor VIII; VWF: von Willebrand factor. APPROVED

Documents
Therapeutic Levels of FVIII Generated by CRISPR/Cas9 ... · Therapeutic Levels of FVIII Generated by CRISPR/Cas9-Mediated In Vivo Genome Editing in Hemophilia A Mice Alan Brooks,

Therapeutic Levels of FVIII Generated by CRISPR/Cas9 ... · Therapeutic Levels of FVIII Generated by CRISPR/Cas9-Mediated In Vivo Genome Editing in Hemophilia A Mice Alan Brooks,

Documents
Characterisation of recombinant FVIII products

Characterisation of recombinant FVIII products

Documents
journal of TM thrombosis and haemostasls Isth WILEY In this … · journal of TM thrombosis and haemostasls Isth WILEY In this issue Duis autem vel eurn iriure dolor in hendrerit

journal of TM thrombosis and haemostasls Isth WILEY In this … · journal of TM thrombosis and haemostasls Isth WILEY In this issue Duis autem vel eurn iriure dolor in hendrerit

Documents
ISTH v50 Porto Rico 2006 Trabalho Filme Morango OFS

ISTH v50 Porto Rico 2006 Trabalho Filme Morango OFS

Documents
Programa academico sin ISTH 12 - congreso.claht.org

Programa academico sin ISTH 12 - congreso.claht.org

Documents
B O S T O n , m A S S A c H u S E T T S ISTH 2009 daIly...JOIn ISTH The hows and whys of ISTH membership 4 GuIDElInE DEvElOPmEnT Translating research into practice requires high quality

B O S T O n , m A S S A c H u S E T T S ISTH 2009 daIly...JOIn ISTH The hows and whys of ISTH membership 4 GuIDElInE DEvElOPmEnT Translating research into practice requires high quality

Documents
MIAMI* (Sunlight Isth All · 2020. 8. 21. · Isth Anniversary November 26" the Sunlight > School of Beauty Culture opens its!] 15th anniversary 4-day celebra-1 scion with a tea and

MIAMI* (Sunlight Isth All · 2020. 8. 21. · Isth Anniversary November 26" the Sunlight > School of Beauty Culture opens its!] 15th anniversary 4-day celebra-1 scion with a tea and

Documents
Tolerance Induction and the Immunobiology of FVIII in

Tolerance Induction and the Immunobiology of FVIII in

Documents
Habitos Estudio Rendimiento Academico Estudiantes Del Isth (1)

Habitos Estudio Rendimiento Academico Estudiantes Del Isth (1)

Documents
Programa academico sin ISTH 17 - congreso.claht.org

Programa academico sin ISTH 17 - congreso.claht.org

Documents
inside: ISTH 2011 in Kyoto a resounding success

inside: ISTH 2011 in Kyoto a resounding success

Documents
Challenges in the Diagnosis and Management of Hemophilia · ISTH Advanced Training Course Dubai, UAE ISTH Advanced Training Course Challenges in the Diagnosis and Management of Hemophilia

Challenges in the Diagnosis and Management of Hemophilia · ISTH Advanced Training Course Dubai, UAE ISTH Advanced Training Course Challenges in the Diagnosis and Management of Hemophilia

Documents
Better answers from high-quality testing · Test Name Test Codes Aliases Panel Components Specimen Requirements Factor VIII Activity, Clotting 347 FVIII activity, functional FVIII,

Better answers from high-quality testing · Test Name Test Codes Aliases Panel Components Specimen Requirements Factor VIII Activity, Clotting 347 FVIII activity, functional FVIII,

Documents
How Full-Length FVIII Benefits from Its Heterogeneity – Insights … · RESEARCH PAPER How Full-Length FVIII Benefits from Its Heterogeneity – Insights into the Role of the B-Domain

How Full-Length FVIII Benefits from Its Heterogeneity – Insights … · RESEARCH PAPER How Full-Length FVIII Benefits from Its Heterogeneity – Insights into the Role of the B-Domain

Documents
Update of von Willebrand Factor Gene Defects from the ISTH VWF Web Site Update of von Willebrand Factor Gene Defects from the ISTH VWF Web Site Anne Goodeve

Update of von Willebrand Factor Gene Defects from the ISTH VWF Web Site Update of von Willebrand Factor Gene Defects from the ISTH VWF Web Site Anne Goodeve

Documents
L’esperienza clinica con il FVIII ricombinante da linea ... · Struttura macromolecolare tridimensionale di una molecola di FVIII umano privo di dominio B evidenzia quattro catene

L’esperienza clinica con il FVIII ricombinante da linea ... · Struttura macromolecolare tridimensionale di una molecola di FVIII umano privo di dominio B evidenzia quattro catene

Documents
POST-ISTH: NOVITA’ DAL MEETING DI TORONTO … · TMAs: Hot topics from the Toronto ISTH meeting (OR153) Endogenous plasmin levels control the development of acute episodes of thrombotic

POST-ISTH: NOVITA’ DAL MEETING DI TORONTO … · TMAs: Hot topics from the Toronto ISTH meeting (OR153) Endogenous plasmin levels control the development of acute episodes of thrombotic

Documents
Case Studies: Congenital Platelet Disorders · Case Studies: Congenital Platelet Disorders Presented to Atlanta ISTH Advanced Training Course Wednesday, November 2, 2016. ISTH Advanced

Case Studies: Congenital Platelet Disorders · Case Studies: Congenital Platelet Disorders Presented to Atlanta ISTH Advanced Training Course Wednesday, November 2, 2016. ISTH Advanced

Documents
SSC Meeting in Conjunction with ISTH 2015 Toronto …c.ymcdn.com/.../Yearly_Subcommittee_Minutes/2015_SSC_Minutes.pdf · SSC Meeting in Conjunction with ISTH 2015 Toronto Congress–

SSC Meeting in Conjunction with ISTH 2015 Toronto …c.ymcdn.com/.../Yearly_Subcommittee_Minutes/2015_SSC_Minutes.pdf · SSC Meeting in Conjunction with ISTH 2015 Toronto Congress–

Documents
ISTH telemed poster Final 6-01-2015 minor edits

ISTH telemed poster Final 6-01-2015 minor edits

Documents
Generation of FVIII-Specific Chimeric Antigen Receptor

Generation of FVIII-Specific Chimeric Antigen Receptor

Documents
Benign Hematology Update: ASH, ISTH, and the Literature 2013

Benign Hematology Update: ASH, ISTH, and the Literature 2013

Documents
Generation of FVIII-Specific Tregs Expressing a Chimeric

Generation of FVIII-Specific Tregs Expressing a Chimeric

Documents
Guideline on recombinant and plasma-derived FVIII products · Timeline history of guideline: The original Note for Guidance on Clinical Investigation of Human Plasma Derived FVIII

Guideline on recombinant and plasma-derived FVIII products · Timeline history of guideline: The original Note for Guidance on Clinical Investigation of Human Plasma Derived FVIII

Documents